
Europe Omega 3 Supplements Market Size, Share & Trends Analysis Report By Functionality, By End Use, By Source, By Distribution Channel, By Form, By Country and Growth Forecast, 2024 - 2031
Description
The Europe Omega 3 Supplements Market would witness market growth of 8.3% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Omega 3 Supplements Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $872.8 million by 2031. UK market is exhibiting a CAGR of 7.4% during (2024 - 2031). Additionally, The France market would experience a CAGR of 9.1% during (2024 - 2031).
The growth of the market reflects broader societal trends, such as the increasing prioritization of wellness, the rise of personalized nutrition, and a growing emphasis on sustainability. Valued at billions of dollars globally, the market encompasses diverse products, from traditional fish oil capsules to plant-based alternatives derived from algae and seeds. This diversity caters to varying dietary needs, including vegetarians, vegans, and individuals with fish allergies.
Moreover, according to recent statistics, the number of vegans in South Africa has doubled in the past five years alone, with an estimated 1% of the population identifying as vegans. Also, as per the U.S. Department of Agriculture, Germany has the highest rate of vegetarianism compared to its European neighbours, and the number of vegans reached over 1.5 million people in 2022.
Europe is witnessing steady growth, driven by increasing health concerns and a growing focus on preventive healthcare. The rising prevalence of neurological disorders and the significant burden of respiratory diseases across the European Union (EU) are key factors fuelling the demand for Omega-3 supplements. With mounting scientific evidence supporting the role of Omega-3 fatty acids in brain health and inflammation reduction, European consumers are increasingly incorporating these supplements into their daily routines. As awareness grows and healthcare systems emphasize disease prevention, the market in Europe is poised for expansion.
Based on Functionality, the market is segmented into Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, and Other Functionality. Based on End Use, the market is segmented into Adults, Geriatric, Pregnant Women, Children, and Infants. Based on Source, the market is segmented into Fish Oil, Algae Oil, Krill Oil, and Other Source. Based on Distribution Channel, the market is segmented into Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Prescribed, and Other Distribution Channel. Based on Form, the market is segmented into Soft Gels, Capsules, Tablets, and Other Form. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
By Functionality
The Germany market dominated the Europe Omega 3 Supplements Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $872.8 million by 2031. UK market is exhibiting a CAGR of 7.4% during (2024 - 2031). Additionally, The France market would experience a CAGR of 9.1% during (2024 - 2031).
The growth of the market reflects broader societal trends, such as the increasing prioritization of wellness, the rise of personalized nutrition, and a growing emphasis on sustainability. Valued at billions of dollars globally, the market encompasses diverse products, from traditional fish oil capsules to plant-based alternatives derived from algae and seeds. This diversity caters to varying dietary needs, including vegetarians, vegans, and individuals with fish allergies.
Moreover, according to recent statistics, the number of vegans in South Africa has doubled in the past five years alone, with an estimated 1% of the population identifying as vegans. Also, as per the U.S. Department of Agriculture, Germany has the highest rate of vegetarianism compared to its European neighbours, and the number of vegans reached over 1.5 million people in 2022.
Europe is witnessing steady growth, driven by increasing health concerns and a growing focus on preventive healthcare. The rising prevalence of neurological disorders and the significant burden of respiratory diseases across the European Union (EU) are key factors fuelling the demand for Omega-3 supplements. With mounting scientific evidence supporting the role of Omega-3 fatty acids in brain health and inflammation reduction, European consumers are increasingly incorporating these supplements into their daily routines. As awareness grows and healthcare systems emphasize disease prevention, the market in Europe is poised for expansion.
Based on Functionality, the market is segmented into Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, and Other Functionality. Based on End Use, the market is segmented into Adults, Geriatric, Pregnant Women, Children, and Infants. Based on Source, the market is segmented into Fish Oil, Algae Oil, Krill Oil, and Other Source. Based on Distribution Channel, the market is segmented into Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Prescribed, and Other Distribution Channel. Based on Form, the market is segmented into Soft Gels, Capsules, Tablets, and Other Form. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Nordic Naturals, Inc.
- Nutrigold Inc.
- Reckitt Benckiser Group PLC
- Aker BioMarine AS
- NOW Foods, Inc.
- Nature's Bounty (Nestlé Health Science S.A.) (Nestle S.A.)
- Amway Corporation
- New Chapter, Inc. (Procter & Gamble Inc.)
- GNC Holdings, LLC
- Pharmavite LLC (Otsuka Pharmaceutical Co., Ltd.)
By Functionality
- Cardiovascular Health
- Brain, Nervous System & Mental Health
- Eye Diseases
- Diabetes
- Other Functionality
- Adults
- Geriatric
- Pregnant Women
- Children
- Infants
- Fish Oil
- Algae Oil
- Krill Oil
- Other Source
- Supermarkets/ Hypermarkets/Food Stores
- Drug Stores & Pharmacies
- Online Retailers
- Prescribed
- Other Distribution Channel
- Soft Gels
- Capsules
- Tablets
- Other Form
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
152 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Omega 3 Supplements Market, by Functionality
- 1.4.2 Europe Omega 3 Supplements Market, by End Use
- 1.4.3 Europe Omega 3 Supplements Market, by Source
- 1.4.4 Europe Omega 3 Supplements Market, by Distribution Channel
- 1.4.5 Europe Omega 3 Supplements Market, by Form
- 1.4.6 Europe Omega 3 Supplements Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
- Chapter 4. Recent Strategies Deployed in Omega 3 Supplements Market
- Chapter 5. Europe Omega 3 Supplements Market by Functionality
- 5.1 Europe Cardiovascular Health Market by Country
- 5.2 Europe Brain, Nervous System & Mental Health Market by Country
- 5.3 Europe Eye Diseases Market by Country
- 5.4 Europe Diabetes Market by Country
- 5.5 Europe Other Functionality Market by Country
- Chapter 6. Europe Omega 3 Supplements Market by End Use
- 6.1 Europe Adults Market by Country
- 6.2 Europe Geriatric Market by Country
- 6.3 Europe Pregnant Women Market by Country
- 6.4 Europe Children Market by Country
- 6.5 Europe Infants Market by Country
- Chapter 7. Europe Omega 3 Supplements Market by Source
- 7.1 Europe Fish Oil Market by Country
- 7.2 Europe Algae Oil Market by Country
- 7.3 Europe Krill Oil Market by Country
- 7.4 Europe Other Source Market by Country
- Chapter 8. Europe Omega 3 Supplements Market by Distribution Channel
- 8.1 Europe Supermarkets/ Hypermarkets/Food Stores Market by Country
- 8.2 Europe Drug Stores & Pharmacies Market by Country
- 8.3 Europe Online Retailers Market by Country
- 8.4 Europe Prescribed Market by Country
- 8.5 Europe Other Distribution Channel Market by Country
- Chapter 9. Europe Omega 3 Supplements Market by Form
- 9.1 Europe Soft Gels Market by Country
- 9.2 Europe Capsules Market by Country
- 9.3 Europe Tablets Market by Country
- 9.4 Europe Other Form Market by Country
- Chapter 10. Europe Omega 3 Supplements Market by Country
- 10.1 Germany Omega 3 Supplements Market
- 10.1.1 Germany Omega 3 Supplements Market by Functionality
- 10.1.2 Germany Omega 3 Supplements Market by End Use
- 10.1.3 Germany Omega 3 Supplements Market by Source
- 10.1.4 Germany Omega 3 Supplements Market by Distribution Channel
- 10.1.5 Germany Omega 3 Supplements Market by Form
- 10.2 UK Omega 3 Supplements Market
- 10.2.1 UK Omega 3 Supplements Market by Functionality
- 10.2.2 UK Omega 3 Supplements Market by End Use
- 10.2.3 UK Omega 3 Supplements Market by Source
- 10.2.4 UK Omega 3 Supplements Market by Distribution Channel
- 10.2.5 UK Omega 3 Supplements Market by Form
- 10.3 France Omega 3 Supplements Market
- 10.3.1 France Omega 3 Supplements Market by Functionality
- 10.3.2 France Omega 3 Supplements Market by End Use
- 10.3.3 France Omega 3 Supplements Market by Source
- 10.3.4 France Omega 3 Supplements Market by Distribution Channel
- 10.3.5 France Omega 3 Supplements Market by Form
- 10.4 Russia Omega 3 Supplements Market
- 10.4.1 Russia Omega 3 Supplements Market by Functionality
- 10.4.2 Russia Omega 3 Supplements Market by End Use
- 10.4.3 Russia Omega 3 Supplements Market by Source
- 10.4.4 Russia Omega 3 Supplements Market by Distribution Channel
- 10.4.5 Russia Omega 3 Supplements Market by Form
- 10.5 Spain Omega 3 Supplements Market
- 10.5.1 Spain Omega 3 Supplements Market by Functionality
- 10.5.2 Spain Omega 3 Supplements Market by End Use
- 10.5.3 Spain Omega 3 Supplements Market by Source
- 10.5.4 Spain Omega 3 Supplements Market by Distribution Channel
- 10.5.5 Spain Omega 3 Supplements Market by Form
- 10.6 Italy Omega 3 Supplements Market
- 10.6.1 Italy Omega 3 Supplements Market by Functionality
- 10.6.2 Italy Omega 3 Supplements Market by End Use
- 10.6.3 Italy Omega 3 Supplements Market by Source
- 10.6.4 Italy Omega 3 Supplements Market by Distribution Channel
- 10.6.5 Italy Omega 3 Supplements Market by Form
- 10.7 Rest of Europe Omega 3 Supplements Market
- 10.7.1 Rest of Europe Omega 3 Supplements Market by Functionality
- 10.7.2 Rest of Europe Omega 3 Supplements Market by End Use
- 10.7.3 Rest of Europe Omega 3 Supplements Market by Source
- 10.7.4 Rest of Europe Omega 3 Supplements Market by Distribution Channel
- 10.7.5 Rest of Europe Omega 3 Supplements Market by Form
- Chapter 11. Company Profiles
- 11.1 Nordic Naturals, Inc.
- 11.1.1 Company Overview
- 11.1.2 Recent strategies and developments:
- 11.1.2.1 Partnerships, Collaborations, and Agreements:
- 11.1.3 SWOT Analysis
- 11.2 Nutrigold Inc.
- 11.2.1 Company Overview
- 11.2.2 SWOT Analysis
- 11.3 Reckitt Benckiser Group PLC
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental and Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 SWOT Analysis
- 11.4 Aker BioMarine AS
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Segmental and Regional Analysis
- 11.4.4 Research & Development Expenses
- 11.4.5 Recent strategies and developments:
- 11.4.5.1 Product Launches and Product Expansions:
- 11.4.6 SWOT Analysis
- 11.5 NOW Foods, Inc.
- 11.5.1 Company Overview
- 11.5.2 Recent strategies and developments:
- 11.5.2.1 Product Launches and Product Expansions:
- 11.5.3 SWOT Analysis
- 11.6 Nature's Bounty (Nestlé Health Science S.A.) (Nestle S.A.)
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Segmental and Regional Analysis
- 11.6.4 Research & Development Expenses
- 11.7 Amway Corporation
- 11.7.1 Company Overview
- 11.7.2 SWOT Analysis
- 11.8 New Chapter, Inc. (Procter & Gamble Inc.)
- 11.8.1 Company Overview
- 11.8.2 Financial Analysis
- 11.8.3 Segmental and Regional Analysis
- 11.8.4 Research & Development Expenses
- 11.8.5 Recent strategies and developments:
- 11.8.5.1 Product Launches and Product Expansions:
- 11.9 GNC Holdings, LLC (Harbin Pharmaceutical Group)
- 11.9.1 Company Overview
- 11.10. Pharmavite LLC (Otsuka Pharmaceutical Co., Ltd.)
- 11.10.1 Company Overview
- 11.10.2 Financial Analysis
- 11.10.3 Segmental & Regional Analysis
- 11.10.4 Research & Development Expense
- 11.10.5 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.